Join us on Tuesday 28th April 2025 for the Lymphoma Hybrid Study Day. A hybrid study day for Nurses/ACP’s and AHP’s involved in the care of patients with lymphoma, aiming to expand specialist knowledge about the holistic care of these patients, with a special focus on the psychological and long term effects of treatment, and […]
VENUE:  The Royal Marsden Education and Conference Centre, Chelsea, Stewart’s Grove, London SW3 6JJ It is with pleasure that we invite you to participate in this very exciting meeting. Start: 08:30, 30 April 2026 End: 17:00, 30 April 2026 Price: £150.00 Event: Study day Introducing the fundamentals of bladder cancer; including signs and symptoms, diagnosis, types of disease […]
Join us on Tuesday 5th May for the Pathology Study Day. This event is Hybrid Overview The Pathology Study Day will provide a basic understanding of the broad range of services provided within Pathology, highlighting the critical role of Pathology in clinical care pathways, and expand knowledge on emerging technologies and areas of research. Intended […]
Hear about exciting clinical developments in breast cancer, explore topics like access to care and navigating difficult conversations with patients, and network with peers from across the UK. Rate: £50 Venue: The Birmingham Rep Theatre and the Library of Birmingham, Centenary Square, Birmingham, B1 2EP Time: 9am - 4.30pm What to expect Innovate, inspire, include Our […]
The Greater Manchester Cancer Conference will return in 2026, bringing together professionals and partners from across the cancer system to share learning, celebrate success and drive continued improvement in cancer care. Taking place on 12 and 13 May 2026 at the Deansgate Hotel (formerly the Hilton Deansgate), the conference remains Greater Manchester Cancer’s flagship event. It provides […]
Friday 15th May 2026 Organised by: Dr Bode Oladipo, Consultant Medical Oncologist, Belfast Health and Social Care Trust Location: Virtual Registration for this event is now open As always, CPD accreditation (6 credits) is being applied for. Please submit your poster abstracts by Sunday 19th April 2026 (250 words maximum) to zoey@melanomafocus.org.Â
The 2026 ASCO Annual Meeting is more than an event—it’s your chance to Be Part of Something Bigger, connect with global colleagues, and immerse yourself in groundbreaking research and innovation. Early registration is open through April 22.
ABS Conference 2026 Join the Association of Breast Surgery for the ABS Conference 2026 in Glasgow on 8 - 9 June, bringing together multidisciplinary teams from across the globe for two days of expert-led education, collaboration and innovation in breast surgery and care. Whether you’re a surgeon, trainee, nurse specialist, researcher or allied health professional, […]
The UK Imaging and Oncology Congress (UKIO) – the UK’s largest multidisciplinary event in the field – returns to Liverpool in June 2026 UKIO 2026 will take place at the ACC Liverpool on 8-10 June with the theme Putting humanity at the centre of healthcare: In the age of the machine – ensuring that as technology rapidly […]
The LCNUK Annual Conference returns to Glasgow on Thursday 18 – Friday 19 June 2026 at the Hilton Hotel. Join lung cancer nurses and navigators from across the UK for two energising days of learning, connection and professional growth. 🙋 Reconnect with colleagues and peers 🎤 Hear from leading experts 💡 Build your professional portfolio […]
The 60th Ophthalmic Oncology Group Meeting will be held in London at The Great Hall, Barts North Wing, EC1 on 2-4 July 2026. Join us for three days of insightful and inspirational talks plus social events which, between them, will provide a fantastic opportunity for learning and to share knowledge and build connections within the ophthalmic […]
Nail damage caused by chemotherapy affects up to 90% of patients, not only causing physical harm, but significantly impacting their quality of life. Due to a historical lack of reliable, evidence-based solutions, nail damage remains an under-diagnosed and under-treated issue in holistic cancer care. Furthermore, emerging evidence shows that some targeted therapies and immunotherapies are […]
